| GA21245-5g |
|
13184-27-5 |
Carbamoyl-Asp-OH . magnesium salt/Carbamoyl-Asp-OH . dipotassium salt (1:1)
|
0 |
C10H12K2MgN4O10 |
|
|
|
| GA21245-1g |
|
13184-27-5 |
Carbamoyl-Asp-OH . magnesium salt/Carbamoyl-Asp-OH . dipotassium salt (1:1)
|
0 |
C10H12K2MgN4O10 |
|
|
|
| GA21244-5mg |
|
100853-58-5 |
cAMP-Dependent Protein Kinase Inhibitor-α (5-22) amide (human, mouse, rabbit, rat)
|
0 |
C84H137N29O26 |
|
|
|
| GA21244-1mg |
|
100853-58-5 |
cAMP-Dependent Protein Kinase Inhibitor-α (5-22) amide (human, mouse, rabbit, rat)
|
0 |
C84H137N29O26 |
|
|
|
| GA21243-1mg |
|
350670-85-8 |
|
0 |
C64H91N19O22 |
|
|
|
| GA21243-005mg |
|
350670-85-8 |
|
0 |
C64H91N19O22 |
|
|
|
| GA21242-1mg |
|
118277-01-3 |
Calcitonin N-Terminal Flanking Peptide (human)
|
0 |
C264H426N74O97S |
|
|
|
| GA21242-005mg |
|
118277-01-3 |
Calcitonin N-Terminal Flanking Peptide (human)
|
0 |
C264H426N74O97S |
|
|
|
| GA21241-5mg |
|
11118-25-5 |
|
0 |
C148H228N40O46S3 |
|
|
|
| GA21241-1mg |
|
11118-25-5 |
|
0 |
C148H228N40O46S3 |
|
|
|
| GA21240-5mg |
|
12321-44-7 |
|
0 |
C159H232N46O45S3 |
|
|
|
| GA21240-1mg |
|
12321-44-7 |
|
0 |
C159H232N46O45S3 |
|
|
|
| GA21239-5mg |
|
100016-62-4 |
|
0 |
C145H240N42O46S2 |
|
|
|
| GA21239-1mg |
|
100016-62-4 |
|
0 |
C145H240N42O46S2 |
|
|
|
| GA21238-5mg |
|
762263-16-1 |
Calcitonin (9-32) (free acid) (human)
|
0 |
C121H176N30O35 |
|
|
|
| GA21238-1mg |
|
762263-16-1 |
Calcitonin (9-32) (free acid) (human)
|
0 |
C121H176N30O35 |
|
|
|
| GA21237-25mg |
|
133214-60-5 |
|
0 |
C51H86N12O9 |
|
|
|
| GA21237-5mg |
|
133214-60-5 |
|
0 |
C51H86N12O9 |
|
|
|
| GA21236-005mg |
|
1816940-05-2 |
C5a Anaphylatoxin (human)
|
0 |
C350H578N108O107S8 |
|
|
|
| GA21236-001mg |
|
1816940-05-2 |
C5a Anaphylatoxin (human)
|
0 |
C350H578N108O107S8 |
|
|
|
